Rocket Pharmaceuticals Inc (NAS:RCKT)
$ 22.72 0.49 (2.2%) Market Cap: 2.06 Bil Enterprise Value: 1.71 Bil PE Ratio: 0 PB Ratio: 4.67 GF Score: 43/100

Rocket Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 07:50PM GMT
Release Date Price: $55.24 (-2.95%)
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

All right. Good afternoon. Thanks, everybody, for joining us for the Annual JPMorgan Healthcare Conference. I'm Eric Joseph, Senior Biotech Analyst at the firm.

Our next presenting company this afternoon is Rocket Pharmaceuticals, and it's my pleasure to welcome CEO, Gaurav Shah, to talk to us a bit about the company.

Just a note before I hand it over, there is a Q&A session after the presentation. Do feel free to submit questions that I can ask on your behalf by clicking the ask-a-question icon. Just to the top right of the webcast.

With that, Gaurav, thanks again for joining us. Take it away.

Gaurav Shah
Rocket Pharmaceuticals, Inc. - CEO, President & Director

Thanks, Eric. Happy New Year to everybody. It's really great to be here again at JPMorgan. So according to the Gregorian calendar, which is the calendar that most people in the world use now. 2021 is actually the start of this decade. We're so excited to be a part of this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot